Data interpretation: using probability
Novel drug targets for the pharmacotherapy of benign prostatic hyperplasia (BPH)
Many ways to dilate the P2X7 receptor pore
Colchicine inhibits cationic dye uptake induced by ATP in P2X2 and P2X7 receptor-expressing cells: implications for its therapeutic action
Defects in mouse nephrogenesis induced by selective and non-selective cyclooxygenase-2 inhibitors
Significantly reduced cytochrome P450 3A4 expression and activity in liver from humans with diabetes mellitus
Mice lacking the Raf-1 kinase inhibitor protein exhibit exaggerated hypoxia-induced pulmonary hypertension
Inhibition of nociceptive responses after systemic administration of amidated kyotorphin
Chronic treatment with angiotensin-(1–7) improves renal endothelial dysfunction in apolipoproteinE-deficient mice
Indirect modulation of neuronal excitability and synaptic transmission in the hippocampus by activation of proteinase-activated receptor-2
A2B adenosine receptors inhibit superoxide production from mitochondrial complex I in rabbit cardiomyocytes via a mechanism sensitive to Pertussis toxin
Central activation of the cholinergic anti-inflammatory pathway reduces surgical inflammation in experimental post-operative ileus
Naringin directly activates inwardly rectifying potassium channels at an overlapping binding site to tertiapin-Q
The GABAB receptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice
Liposome-encapsulated dexamethasone attenuates ventilator-induced lung inflammation
Increased availability of angiotensin AT1 receptors leads to sustained arterial constriction to angiotensin II in diabetes – role for Rho-kinase activation
P2X4 receptors interact with both P2X2 and P2X7 receptors in the form of homotrimers
AVE3085, an enhancer of endothelial nitric oxide synthase, restores endothelial function and reduces blood pressure in spontaneously hypertensive rats
Roscovitine blocks leukocyte extravasation by inhibition of cyclin-dependent kinases 5 and 9
Carvedilol targets human K2P3.1 (TASK1) K+ leak channels